Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of November 2019. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for December 12, 2019, at the company's offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on corporate governance procedures for the upcoming annual meeting.
Guidance, Outlook, and Management Commentary
The filing includes no management commentary on business outlook, risks, contingencies, or unusual items. It strictly details the logistics of the Annual General Meeting, including the date, time, and location, and lists attached exhibits containing the Notice and Proxy Statement, Proxy Card, and Voting Instruction Card.
Key Facts for Investor Verification
- Annual General Meeting Date: December 12, 2019.
- Meeting Time: 12:00 p.m. (Israel time).
- Meeting Location: 10 Bareket Street, Petach Tikva, Israel.
- Shareholders may vote in person or by proxy using the attached forms.
- This filing incorporates by reference into the company's Registration Statements on Form S-8 and Form F-3.